Table 2. Cognitive and neuropsychological data (baseline and after 6 months).
|
|
p-value | |
---|---|---|---|
MoCA | |||
Global score | 22.0 (5.8) | 22.8 (6.2) | 0.094 |
<26 | 31.0 (63.2) | 18.0 (62.0) | 0.916 |
18-25 | 20.0 (40.8) | 12.0 (41.3) | 0.961 |
10-17 | 9.0 (18.3) | 5.0 (17.2) | 0.900 |
≥26 | 18.0 (36.7) | 11.0 (37.9) | 0.916 |
TMT | |||
A sec | 96.8 (74.6) | 89.9 (53.1) | 0.854 |
A errors | 0.7 (1.0) | 7.5 (38.5) | 0.106 |
B sec | 174.5 (104.1) | 160.6 (67.1) | 0.163 |
B errors | 2.0 (1.7) | 1.7 (1.8) | 0.029* |
(B-A) | 77.7 (51.3) | 70.7 (40.7) | 0.225 |
Verbal fluency | |||
Categorical (animals) | 15.2 (6.5) | 16.4 (7.1) | 0.058 |
HAD | |||
Depression | 9.3 (5.3) | 7.6 (4.2) | 0.296 |
Anxiety | 9.7 (4.6) | 9.6 (5.0) | 0.868 |
Cognitive complaints | |||
Emphasized | 93.5% | 88.6% | - |
Detailed | 88.7% | 76.3% | - |
Abbreviations: MoCA, Montreal Cognitive Assessment; TMT, Trail Making Test; HAD, Hospital Depression and Anxiety Scale.
Note: Wilcoxon test (Wilcoxon matched-pairs or Wilcoxon signed-rank test). *Significance level <0.05.